Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625321 | SCV000744934 | likely benign | Leber congenital amaurosis 9 | 2017-06-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000625321 | SCV001020991 | benign | Leber congenital amaurosis 9 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000625321 | SCV001367760 | likely benign | Leber congenital amaurosis 9 | 2019-03-27 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely benign. The following ACMG criteria were applied in classifying this variant: BS1,BP4. |
Ce |
RCV003424194 | SCV004128338 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | NMNAT1: BP4, BS2 |
Breakthrough Genomics, |
RCV003424194 | SCV005257466 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001700421 | SCV001923426 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003905671 | SCV004719780 | benign | NMNAT1-related disorder | 2019-07-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |